 | |
| Company type | Public Sector Undertaking |
|---|---|
| BSE: 524663 | |
Key people | Sh. Chaitanya Murti IFS (Managing Director) |
| Products | Polio vaccine |
| Owner | Government of India |
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Public Sector Undertaking (PSU) of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines (OPVs) and other immunisers.[1] The company formulates over 12.5 crore doses of OPV and had aggregated revenues of ₹30.5 crore (equivalent to ₹98 crore or US$12 million in 2023) in fiscal 2006.[2][3]
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology.
YouTube Encyclopedic
-
1/2Views:32 719566
-
CAREERS IN BIOTECHNOLOGY ENGINEERING – BE,BTECH,EAMCET,JEEE,ECET,DEGREE ,ENGINEERING
-
Bharat Dynamics Limited Recruitment Apply Online Notifications Careers Vacancy
Transcription
Products
- Diarrhea Management Kit—Diarrhea Management Kit (Zinc Tablet + oral rehydration salts (ORS)) for management of diarrhea among young children.
- Oral Polio Vaccine—The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1, 2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary by monkey kidney cell culture.
- Zinc Dispersible Tablet—The dispersible zinc tablet, BIBZinC-20 mg contains 20 mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of the WHO. The product is produced with technology transfer from Nutriset through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
- IFA Tablets—Iron-deficiency anemia (IDA) is most ignored in developing countries and is the major cause of anemia. The Iron Folic Tablets (IFA Tablets) are a crucial component for treatment of iron deficiency and IDA.
See also
References
- ^ "BIBCOL to manufacture 20 million doses of 'covaxin' every month | Web News Observer". 12 May 2021. Retrieved 12 May 2021.
- ^ Company Profile. Department of Biotechnology.
- ^ Financial Statement. Department of Public Enterprise
  | This article about an Indian company is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 13 May 2024, at 21:47